|
What is P2C2? Why am I receiving this newsletter?
Your access to customized, compounded medicines is at risk. Pharmaceutical manufacturers and the FDA are pushing policies that would make it harder for professionals to prescribe, pharmacists to prepare and patients to take compounded medicines.
That's why Patients and Professionals for Customized Care, also known as P2C2, is bringing together people who rely on customized, compounded medicines for better health. Whether you are a patient or a physician, a pet owner or a veterinarian, P2C2 will give you the tools you need to keep pharmaceutical manufacturers and the FDA from restricting your access to compounded medicines.
With your free membership to P2C2, you'll be receiving Custom Care Times, an electronic newsletter that will keep you up-to-date on the latest news and information that affects your ability to take or prescribe compounded medications.
Custom Care Times will let you know when your action is needed, and P2C2 will give you the online tools to let your representative in Congress, officials at the FDA or even relevant members of the media know that you or your patients rely on compounded medicines and that you are committed to making sure they remain available.
Our strength is in our numbers. The more patients, physicians, pet owners or veterinarians we have fighting for compounded medicines, the more successful, we'll be. Forward this newsletter to your friends. Tell them to join the fight.
If you received this newsletter from P2C2 directly, you are already a member. If a friend forwarded this newsletter to you, join P2C2 for free by clicking here.
Contact Us
info@savemymedicine.org
281.933.8400 |
50,000 Patients, Physicians and Pharmacists to Wyeth and FDA:
Keep Your Hands Off Our Hormones!
In October 2005, Wyeth filed a citizen petition with the FDA to restrict the prescription and preparation of bio-identical hormones. Since then, more than 50,000 people have filed comments opposing them.
Thousands of women suffering from the painful symptoms of menopause and hormone imbalance are being prescribed this treatment by their doctors.
Wyeth's petition raised a number of points that were false or misleading, and called for enforcement actions ranging from seizures to warning letters against pharmacies preparing bio-identical hormones.
Fortunately, thanks to you, the FDA has heard about the positive effects of BHRT on thousands of women's lives, and the importance of preserving choice for patients and doctors to treat symptoms of menopause. In just six months, more than 50,000 patients, prescribers, and pharmacists wrote to the FDA opposing Wyeth's petition.
The FDA extended its deadline to rule on the issue, leaving the comment period open. If you have not yet written to the FDA, there's still time. Click here to write to FDA now.
To read recent media coverage of the Wyeth citizen petition, check out the articles below:
Hormone Battle: Big Pharma vs. Small Biz
The debate surrounding prescription hormones for women has pitted a pharmaceutical giant against small pharmacies.
BusinessWeek, April 13, 2006
New Controversy Over Menopause Hormones
The FDA gets a flood of responses from patients, physicians and pharmacists opposing Wyeth's controversial petition.
The Wall Street Journal (reprinted in the Pittsburgh Post-Gazette), May 2, 2006 |
|
